We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.44B
AUM Growth
+$259M
(+4.2%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
3.52%
Top 10 Holdings %
Top 10 Hldgs %
34.31%
Holding
1,318
New
461
Increased
339
Reduced
236
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$330M |
| 2 |
Brookdale Senior Living
BKD
|
+$93.7M |
| 3 |
Tenet Healthcare
THC
|
+$85.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$70.6M |
| 5 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$206M |
| 2 |
CVS Health
CVS
|
+$122M |
| 3 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$102M |
| 4 |
McKesson
MCK
|
+$80.6M |
| 5 |
Pacira BioSciences
PCRX
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Miscellaneous | 9.89% |
| 3 | Energy | 6.47% |
| 4 | Consumer Discretionary | 5.67% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
KeyCorp
KEY
$22.8B
| $1.23M | 0.02% |
85,857
-113,709
| -57% | -$1.57M |
|
|
477
CVS Health
CVS
$119B
| $1.2M | 0.02% |
15,930
-1,616,923
| -99% | -$122M |
|
|
LNKD
478
DELISTED
LinkedIn Corporation
LNKD
| $1.19M | 0.02% |
6,936
-11,162
| -62% | -$1.8M |
|
479
Yelp
YELP
$1.13B
| $1.16M | 0.02% |
15,133
+5,759
| +61% | +$375K |
|
|
FDO
480
DELISTED
FAMILY DOLLAR STORES
FDO
| $1.16M | 0.02% |
17,544
+8,319
| +90% | +$501K |
|
481
Microchip Technology
MCHP
$38.9B
| $1.15M | 0.02% |
47,300
+38,786
| +456% | +$925K |
|
482
Vulcan Materials
VMC
$32.3B
| $1.15M | 0.02% |
18,017
+13,335
| +285% | +$844K |
|
483
Old Republic International
ORI
$9.89B
| $1.15M | 0.02% |
69,406
+32,593
| +89% | +$544K |
|
484
Harley-Davidson
HOG
$2.86B
| $1.15M | 0.02% |
16,426
+2,972
| +22% | +$209K |
|
|
MRGE
485
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $1.14M | 0.02% |
500,000
| – | – |
|
486
AMC Global Media
AMCX
$501M
| $1.13M | 0.02% |
18,304
+14,168
| +343% | +$906K |
|
487
PPG Industries
PPG
$23.5B
| $1.13M | 0.02% |
10,708
-9,540
| -47% | -$946K |
|
488
Rio Tinto
RIO
$158B
| $1.1M | 0.02% |
20,358
-7,742
| -28% | -$420K |
|
|
KG
489
Kestrel Group
KG
$47M
| $1.1M | 0.02% |
+4,567
| New | +$1.11M |
|
490
Texas Capital Bancshares
TCBI
$4.22B
| $1.1M | 0.02% |
+20,464
| New | +$1.15M |
|
491
Baxter International
BAX
$12.1B
| $1.09M | 0.02% |
27,766
+16,352
| +143% | +$654K |
|
492
Lumen
LUMN
$7.13B
| $1.08M | 0.02% |
29,918
+15,058
| +101% | +$541K |
|
493
CME Group
CME
$97.6B
| $1.08M | 0.02% |
15,230
+8,957
| +143% | +$630K |
|
|
AGN
494
PUT
DELISTED
Allergan Inc
AGN
| $1.08M | 0.02% |
+101,600
| New | +$15.8M |
|
|
SNI
495
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $1.07M | 0.02% |
+13,212
| New | +$1.01M |
|
|
QLIK
496
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $1.07M | 0.02% |
+47,243
| New | +$1.08M |
|
|
FITB
497
Fifth Third Bancorp
FITB
$48.8B
| $1.06M | 0.02% |
49,814
-11,275
| -18% | -$239K |
|
|
PAY
498
DELISTED
Verifone Systems Inc
PAY
| $1.06M | 0.02% |
+28,923
| New | +$986K |
|
499
Consolidated Edison
ED
$39.1B
| $1.06M | 0.02% |
18,292
-15,593
| -46% | -$871K |
|
|
SWN
500
DELISTED
Southwestern Energy Company
SWN
| $1.06M | 0.02% |
+23,222
| New | +$1.08M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Visium Asset Management held 1,318 positions worth $6.44B, up 4.2% from $6.18B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Visium Asset Management deployed $227M of net new capital in Q2 2014, opening 461 new positions and adding to 339 existing holdings. Its largest new stake was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 56% a quarter earlier, followed by Miscellaneous and Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $206M trimmed.
- Visium Asset Management's largest Q2 2014 buy was NPS PHARMACEUTICALS INC: 1,020,622 shares worth $33.7M.
- Visium Asset Management added most to Allergan Inc in Q2 2014, an estimated $330M increase.
- Visium Asset Management's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $206M.
- Visium Asset Management fully exited QUESTCOR PHARMA INC in Q2 2014, selling an estimated $34M.
- Visium Asset Management's ten largest holdings make up 34% of its $6.44B portfolio in Q2 2014.
- Visium Asset Management opened 461 new positions and closed 232 in Q2 2014.
- Visium Asset Management's portfolio value rose 4.2% quarter-over-quarter to $6.44B.
Based on Visium Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.